![](https://investorshub.advfn.com/uicon/60294.png?cb=1611719355)
Saturday, July 08, 2017 10:18:21 AM
IMO there most definitely is FDA and $ELTP discussions to get Reformulated SequestOx ASAP without any further testing and monies.
First of all, there is no "Reformulated" in this PR to discuss.
It is SequestOx period, no ifs ands or buts. Does anyone know what the time to max concentration was during the first go around? Maybe there was no significant change in Tmax with the reformulated version of SequestOx.
Secondly, all other testing is suspended until Elite meets with the FDA to discuss other options Elite may have or not have.
Tmax data for this study was not within the expected range, equal to or better than the comparator, therefore it makes no sense to go ahead with further testing until one meets with the FDA for a discussion on current results. A 1.2 hour average over the comparator is not very good. 15-30 minutes would have been much better IMO. Anything over that is why there was disappointment about the results. That said, it is what it is.
Will just have to wait and see what gives. You are right about Eugene Pfiefer, that he has experienced such matters in his long career, of that I am sure. Whether he can be of some help in this matter, I do not know.
Maybe they revisit the labeling again. Who knows?
The ONE THING we all know Lasers, is that there is a desperate need for an abuse deterrent formulation that can actually deter abuse without being compromised. Elite has that formulation.
Now what Scott Gottlieb does with this IR drug is up to him.
If proper labeling is given as to not to take this an hour or two before or after eating a fat heavy meal, or however the FDA deems fit, then maybe it flies with labeling. Who knows?
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM